share_log

Wells Fargo Initiates Coverage On Ironwood Pharmaceuticals With Overweight Rating, Announces Price Target of $20

Wells Fargo Initiates Coverage On Ironwood Pharmaceuticals With Overweight Rating, Announces Price Target of $20

富国银行以增持评级启动对Ironwood Pharmicals的报道,宣布目标股价为20美元
Benzinga ·  2023/12/14 07:39

富国银行分析师莫希特·班萨尔以增持评级开始对艾恩伍德制药(纳斯达克股票代码:IRWD)进行报道,并宣布目标股价为20美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发